Optimal management of esophageal adenocarcinoma: should we be CROSS?
- PMID: 25071100
- DOI: 10.1200/JCO.2014.55.5243
Optimal management of esophageal adenocarcinoma: should we be CROSS?
Comment in
-
Reply to E. C. Smyth et al.J Clin Oncol. 2014 Sep 20;32(27):3082. doi: 10.1200/JCO.2014.56.3874. Epub 2014 Jul 28. J Clin Oncol. 2014. PMID: 25071102 No abstract available.
-
Reply to E. C. Smyth et al.J Clin Oncol. 2014 Sep 20;32(27):3081-2. doi: 10.1200/JCO.2014.56.3866. Epub 2014 Jul 28. J Clin Oncol. 2014. PMID: 25071131 No abstract available.
Comment on
-
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.J Clin Oncol. 2014 Feb 10;32(5):385-91. doi: 10.1200/JCO.2013.51.2186. Epub 2014 Jan 13. J Clin Oncol. 2014. PMID: 24419108 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
